Dr David Michael Brown, MD | |
3445 High Point Blvd, Suite 400, Bethlehem, PA 18017-7809 | |
(610) 866-5555 | |
(610) 866-3151 |
Full Name | Dr David Michael Brown |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 18 Years |
Location | 3445 High Point Blvd, Bethlehem, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720246689 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | MD443715 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
St Lukes Quakertown Hospital | Quakertown, PA | Hospital |
St Luke's Hospital - Anderson Campus | Easton, PA | Hospital |
St Luke's Hospital - Monroe Campus | Stroudsburg, PA | Hospital |
St Luke's Warren Hospital | Phillipsburg, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Specialty Physician Associates, Llc | 6204012016 | 38 |
News Archive
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Firmenich SA, the world's largest privately-owned fragrance and flavor company, has made a decision to proceed with commercial development of S6973, Senomyx's enhancer of sucrose (table sugar) that has demonstrated the ability to reduce up to 50% of the sugar in a variety of products while maintaining the taste of natural sugar.
3Pea International Inc., a payment solutions company, today announced that it has filed a registration statement on Form 10 with the Securities and Exchange Commission (SEC) to register its common stock pursuant to Section 12(g) of the Securities Exchange Act of 1934.
Northwestern University's Charles Bennett, M.D., is a super sleuth of potentially deadly prescription drug reactions.
Now, in new research published on the preprint server bioRxiv European scientists have performed RNA structure probing to obtain a single-base resolution secondary structure map of the full SARS-CoV-2 coronavirus genome.
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, today announces a strategic collaboration with ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc.. Under the agreement, Scancell and ImmuneRegen will work together to investigate the synergy between ImmuneRegen's Homspera® and Scancell's ImmunoBody® vaccine technologies.
› Verified 7 days ago
Entity Name | St Lukes Warren Physician Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467725184 PECOS PAC ID: 9739093675 Enrollment ID: O20031117000020 |
News Archive
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Firmenich SA, the world's largest privately-owned fragrance and flavor company, has made a decision to proceed with commercial development of S6973, Senomyx's enhancer of sucrose (table sugar) that has demonstrated the ability to reduce up to 50% of the sugar in a variety of products while maintaining the taste of natural sugar.
3Pea International Inc., a payment solutions company, today announced that it has filed a registration statement on Form 10 with the Securities and Exchange Commission (SEC) to register its common stock pursuant to Section 12(g) of the Securities Exchange Act of 1934.
Northwestern University's Charles Bennett, M.D., is a super sleuth of potentially deadly prescription drug reactions.
Now, in new research published on the preprint server bioRxiv European scientists have performed RNA structure probing to obtain a single-base resolution secondary structure map of the full SARS-CoV-2 coronavirus genome.
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, today announces a strategic collaboration with ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc.. Under the agreement, Scancell and ImmuneRegen will work together to investigate the synergy between ImmuneRegen's Homspera® and Scancell's ImmunoBody® vaccine technologies.
› Verified 7 days ago
Entity Name | Specialty Physician Associates, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1487960639 PECOS PAC ID: 6204012016 Enrollment ID: O20130412000391 |
News Archive
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Firmenich SA, the world's largest privately-owned fragrance and flavor company, has made a decision to proceed with commercial development of S6973, Senomyx's enhancer of sucrose (table sugar) that has demonstrated the ability to reduce up to 50% of the sugar in a variety of products while maintaining the taste of natural sugar.
3Pea International Inc., a payment solutions company, today announced that it has filed a registration statement on Form 10 with the Securities and Exchange Commission (SEC) to register its common stock pursuant to Section 12(g) of the Securities Exchange Act of 1934.
Northwestern University's Charles Bennett, M.D., is a super sleuth of potentially deadly prescription drug reactions.
Now, in new research published on the preprint server bioRxiv European scientists have performed RNA structure probing to obtain a single-base resolution secondary structure map of the full SARS-CoV-2 coronavirus genome.
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, today announces a strategic collaboration with ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc.. Under the agreement, Scancell and ImmuneRegen will work together to investigate the synergy between ImmuneRegen's Homspera® and Scancell's ImmunoBody® vaccine technologies.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David Michael Brown, MD 3445 High Point Blvd, Suite 400, Bethlehem, PA 18017-7809 Ph: (610) 866-5555 | Dr David Michael Brown, MD 3445 High Point Blvd, Suite 400, Bethlehem, PA 18017-7809 Ph: (610) 866-5555 |
News Archive
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Firmenich SA, the world's largest privately-owned fragrance and flavor company, has made a decision to proceed with commercial development of S6973, Senomyx's enhancer of sucrose (table sugar) that has demonstrated the ability to reduce up to 50% of the sugar in a variety of products while maintaining the taste of natural sugar.
3Pea International Inc., a payment solutions company, today announced that it has filed a registration statement on Form 10 with the Securities and Exchange Commission (SEC) to register its common stock pursuant to Section 12(g) of the Securities Exchange Act of 1934.
Northwestern University's Charles Bennett, M.D., is a super sleuth of potentially deadly prescription drug reactions.
Now, in new research published on the preprint server bioRxiv European scientists have performed RNA structure probing to obtain a single-base resolution secondary structure map of the full SARS-CoV-2 coronavirus genome.
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, today announces a strategic collaboration with ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc.. Under the agreement, Scancell and ImmuneRegen will work together to investigate the synergy between ImmuneRegen's Homspera® and Scancell's ImmunoBody® vaccine technologies.
› Verified 7 days ago
Narges Mazloom, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3445 High Point Blvd, Suite 400, Bethlehem, PA 18017 Phone: 610-866-5555 Fax: 610-866-3151 | |
Shriya Airen, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 3445 High Point Blvd Ste 400, Bethlehem, PA 18017 Phone: 484-503-4005 | |
Dr. Aaron Jordon Jaworek, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3445 High Point Blvd Ste 400, Bethlehem, PA 18017 Phone: 610-866-5555 Fax: 610-866-3151 | |
Andrew Pestcoe, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2597 Schoenersville Rd Ste 205, Bethlehem, PA 18017 Phone: 610-691-2552 Fax: 610-882-0445 | |
Glenn M Kaye, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2851 Baglyos Cir, Suite 201, Bethlehem, PA 18020 Phone: 610-867-7134 Fax: 610-867-7108 | |
Dr. Ahmad Issam Mahmoud Abualsoud, MBBCH Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3445 High Point Blvd Ste 400, Bethlehem, PA 18017 Phone: 610-866-5555 Fax: 610-866-3151 | |
Maria Katherine Pomponio, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 3445 High Point Blvd Ste 400, Bethlehem, PA 18017 Phone: 484-503-4005 |